# Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.

> **NCT03074357** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 68 (actual)

## Conditions studied

- Alport Nephropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03074357
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-04
- **Primary completion:** 2018-03-23
- **Final completion:** 2018-03-23
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03074357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03074357, "Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03074357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*